James E Fickenscher - Net Worth and Insider Trading
James E Fickenscher Net Worth
The estimated net worth of James E Fickenscher is at least $2 Million dollars as of 2024-04-27. James E Fickenscher is the Senior Vice President & CFO of Antares Pharma Inc and owns about 270,216 shares of Antares Pharma Inc (ATRS) stock worth over $2 Million. James E Fickenscher is also the CFO of Zynerba Pharmaceuticals Inc and owns about 378,087 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $491,513. Details can be seen in James E Fickenscher's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James E Fickenscher has not made any transactions after 2023-09-13 and currently still holds the listed stock(s).
Transaction Summary of James E Fickenscher
James E Fickenscher Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James E Fickenscher owns 2 companies in total, including Zynerba Pharmaceuticals Inc (ZYNE) , and Antares Pharma Inc (ATRS) .
Click here to see the complete history of James E Fickenscher’s form 4 insider trades.
Insider Ownership Summary of James E Fickenscher
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZYNE | Zynerba Pharmaceuticals Inc | 2023-09-13 | Chief Financial Officer |
| ATRS | Antares Pharma Inc | 2016-03-18 | Senior Vice President & CFO |
James E Fickenscher Latest Holdings Summary
James E Fickenscher currently owns a total of 2 stocks. Among these stocks, James E Fickenscher owns 270,216 shares of Antares Pharma Inc (ATRS) as of March 18, 2016, with a value of $2 Million and a weighting of 75.45%. James E Fickenscher also owns 378,087 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of September 13, 2023, with a value of $491,513 and a weighting of 24.55%.
Latest Holdings of James E Fickenscher
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATRS | Antares Pharma Inc | 2016-03-18 | 270,216 | 5.59 | 1,510,507 |
| ZYNE | Zynerba Pharmaceuticals Inc | 2023-09-13 | 378,087 | 1.30 | 491,513 |
Holding Weightings of James E Fickenscher
James E Fickenscher Form 4 Trading Tracker
According to the SEC Form 4 filings, James E Fickenscher has made a total of 0 transactions in Antares Pharma Inc (ATRS) over the past 5 years. The most-recent trade in Antares Pharma Inc is the acquisition of 135,000 shares on March 18, 2016, which cost James E Fickenscher around $97,200.
According to the SEC Form 4 filings, James E Fickenscher has made a total of 3 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Zynerba Pharmaceuticals Inc is the sale of 8,998 shares on September 13, 2023, which brought James E Fickenscher around $11,967.
Insider Trading History of James E Fickenscher
- 1
James E Fickenscher Trading Performance
GuruFocus tracks the stock performance after each of James E Fickenscher's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James E Fickenscher is 1.83%. GuruFocus also compares James E Fickenscher's trading performance to market benchmark return within the same time period. The performance of stocks bought by James E Fickenscher within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James E Fickenscher's insider trading performs compared to the benchmark.
Performance of James E Fickenscher
Average Return
70.01%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.25 | 1.83 | 18.14 | 70.01 | 1.17 | -2.29 |
| Relative Return to S&P 500(%) | 11.66 | 0.45 | 13.95 | 57.79 | -9.46 | -13.67 |
James E Fickenscher Ownership Network
Ownership Network List of James E Fickenscher
Ownership Network Relation of James E Fickenscher
James E Fickenscher Owned Company Details
What does Zynerba Pharmaceuticals Inc do?
Who are the key executives at Zynerba Pharmaceuticals Inc?
James E Fickenscher is the Chief Financial Officer of Zynerba Pharmaceuticals Inc. Other key executives at Zynerba Pharmaceuticals Inc include director & Chairman & Chief Exec. Officer Armando Anido , President Terri B Sebree , and VP & Commercial & Business Dev. Brian Rosenberger .
Zynerba Pharmaceuticals Inc (ZYNE) Insider Trades Summary
Over the past 18 months, James E Fickenscher made 2 insider transaction in Zynerba Pharmaceuticals Inc (ZYNE) with a net sale of 26,767. Other recent insider transactions involving Zynerba Pharmaceuticals Inc (ZYNE) include a net sale of 53,283 shares made by Armando Anido , a net sale of 37,062 shares made by Terri B Sebree , and a net sale of 19,074 shares made by Brian Rosenberger .
In summary, during the past 3 months, insiders sold 0 shares of Zynerba Pharmaceuticals Inc (ZYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 139,381 shares of Zynerba Pharmaceuticals Inc (ZYNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 139,381 shares.
Zynerba Pharmaceuticals Inc (ZYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zynerba Pharmaceuticals Inc Insider Transactions
James E Fickenscher Mailing Address
Above is the net worth, insider trading, and ownership report for James E Fickenscher. You might contact James E Fickenscher via mailing address: C/o Auxilium Pharmaceuticals, Inc., 640 Lee Road, Chesterbrook Pa 19087.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
